N-104

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameN-104
Drug Alias NamelacripepTM-like peptide (University of Virginia)N-104
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIslet Cell Transplant Rejection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Virginia
Active IndicationsN/A
Inactive IndicationsIslet Cell Transplant Rejection

Other Information

ATC CodeN/A
Related LinksN/A